Saturday, October 29, 2016 Cincinnati, Ohio

15th Annual Psychopharmacology Update: Psychiatric Pharmacotherapies:
Controversies, Evidence and Best Practices

Sessions are scheduled for 60 minutes, with the last 15 for Q&A
Agenda is subject to change. Please check back for updates.

Saturday, October 29, 2016
6:30 am – 7:30 am Registration and Breakfast
7:30 am – 8:30 am Breakfast Symposium (Non-CME)
Treating Hallucinations and Delusions
Associated With Parkinson’s Disease Psychosis
Faculty: Henry A. Nasrallah, MD
Alberto J. Espay, MD, MSc, FAAN, FANA
Sponsored by: ACADIA Pharmaceuticals
8:30 am – 8:40 am Welcome and Introduction
Henry A. Nasrallah, MD

8:40 am – 9:40 am Controversy I
Antidepressants Should Never Be Used for Bipolar Depression
Joseph F. Goldberg, MD

9:40 am – 10:40 am Controversy II
Is Lithium or Anticonvulsants Preferable in Bipolar Disorder?
Roger S. McIntyre, MD

10:40 am – 11:05 am Break

11:05 am – 12:05 pm Controversy III
Treatment-Resistant Depression: Are Adjunctive Therapies Better than Switching to Other Agents?
Joseph F. Goldberg, MD

12:05 pm – 1:05 pm Controversy IV
Is adult ADHD a Variant of Bipolar Disorder or a Separate Disorder?
David Goodman, MD

1:05 pm – 2:20 pm Lunch Symposium (Non-CME)
Clinical Experts in Bipolar Depression
Diagnosis and Management: From Clinical Data to Clinical Practice
Faculty: Roger McIntyre, MD, FRCPC
Sponsored by: Sunovion Pharmaceuticals Inc.

2:20 pm – 2:35 pm Dessert Break/Exhibits

2:35 pm – 3:35pm Controversy V
Long-Acting Injectable Antipsychotics Should Be Used Following the First Episode of Schizophrenia
Henry A. Nasrallah, MD

3:35 pm – 4:35 pm Controversy VI
Controversies in the Pharmacotherapy of Child and Adolescent Psychiatry
Melissa P. DelBello, MD

4:35 pm – 4:50 pm Break

4:50 pm – 5:50 pm Controversy VII
A Post-CATIE Perspective: Neurobiological Effects of Typical vs Atypical Antipsychotics Neuroprotoxicity vs Neuroprotection
Henry A. Nasrallah, MD

5:50 pm – 6:20 pm Q&A with Faculty Panel